Displaying 109 - 120 of 288
Metabolism, Alcohol & Toxicity

Session 3: Treating patients with NASH and Significant Fibrosis, what the future holds?

Webcasts
View
Metabolism, Alcohol & Toxicity

Discussion

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Welcome and a journey back to 1992

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Personal perspectives: What is the most significant advance in the last 10 years?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Snapshot in 2022 and beyond: Where are we now and what do we need to achieve?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Personal priorities

Webcasts
View
General Hepatology

What is the impact of cholestatic liver disease on the patient?

Webcasts
View
General Hepatology

Management of cholestatic liver diseases

Webcasts
View
General Hepatology

Q&A and close

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Welcome and introduction

Webcasts
View
Immune-Mediated and Cholestatic Diseases

PFIC in practice: Paediatric and adult case studies of patients with idiopathic cholestasis

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Q&A

Webcasts
View
Displaying 109 - 120 of 288